Enteric Glia Regulate Lymphocyte Activation via Autophagy-Mediated MHC-II Expression.

Area of Science:

• Immunology
• Neuroscience
• Gastroenterology

Background:

• Enteric glial cells express Major Histocompatibility Complex-II (MHC-II) in inflammatory conditions like Crohn's disease.
• The functional role and immunomodulatory capacity of glial MHC-II remain largely uncharacterized.

Purpose of the Study:

• To investigate the antigen-presenting capabilities of enteric glia in vivo.
• To determine the immunomodulatory effects of glial MHC-II on intestinal immune cells.

Main Methods:

• Generated genetically modified mice to specifically ablate MHC-II in enteric glia.
• Assessed glial phagocytosis and autophagy.
• Measured T- and B-lymphocyte activation and cytokine profiles in vivo.

Main Results:

• Enteric glia express MHC-II in response to inflammatory stimuli (interferon-γ and lipopolysaccharide).
• Glial MHC-II is crucial for effective T- and B-lymphocyte activation, notably impacting T-helper 17 and regulatory T cell subsets.
• Glial MHC-II expression is dependent on autophagy activation but does not significantly alter systemic cytokine levels.

Conclusions:

• Enteric glia utilize MHC-II expression to modulate intestinal immune responses and promote immune tolerance.
• Glial antigen presentation, triggered by inflammatory stimuli and autophagy, fine-tunes T-lymphocyte subsets.
• Enteric glia play a key role in maintaining intestinal immune homeostasis during inflammation, relevant to diseases like Crohn's.